J. Jones

发表

Synthesis and evaluation of 2-pyridinone derivatives as HIV-1-specific reverse transcriptase inhibitors. 2. Analogues of 3-aminopyridin-2(1H)-one.

Christopher M Thomas, W. S. Saari, J. Hoffman, 1992, Journal of medicinal chemistry.

Synthesis and evaluation of 2-pyridinone derivatives as HIV-1-specific reverse transcriptase inhibitors. 4. 3-[2-(Benzoxazol-2-yl)ethyl]-5-ethyl-6-methylpyridin-2(1H)-one and analogues.

Christopher M Thomas, J. Hoffman, J. Wai, 1993, Journal of medicinal chemistry.

Synthesis and biological activities of [7-(azetidine-2-carboxylic acid)]-oxytocin and -lysine-vasopressin.

A. Hudson, J. Jones, H. Chowdrey, 2009, International journal of peptide and protein research.

Potent dopamine agonist activity of a novel ergoline, 6-ethyl-9-oxaergoline (EOE).

M. Williams, J. Jones, G. Yarbrough, 1982, Life sciences.

Discovery of Potent, Selective, and Brain-Penetrant Apoptosis Signal-Regulating Kinase 1 (ASK1) Inhibitors that Modulate Brain Inflammation In Vivo.

I. Enyedy, Janaky Coomaraswamy, J. Jones, 2021, Journal of medicinal chemistry.

Discovery of CNS-Penetrant Apoptosis Signal-Regulating Kinase 1 (ASK1) Inhibitors.

I. Enyedy, J. Jones, J. Santoro, 2020, ACS medicinal chemistry letters.

Different actions of TL-99 and 3-PPP in producing contraversive turning in the 6-OHDA-lesioned rat.

J. Jones, G. Martin, R. Bendesky, 1983, European journal of pharmacology.

Discovery of 3-[(4,5,7-trifluorobenzothiazol-2-yl)methyl]indole-N-acetic acid (lidorestat) and congeners as highly potent and selective inhibitors of aldose reductase for treatment of chronic diabetic complications.

T. Petrova, J. Sredy, D. Sawicki, 2005, Journal of medicinal chemistry.

Optimization of the 4-aryl group of 4-aryl-pyridine glucagon antagonists: development of an efficient, alternative synthesis.

J. Livingston, J. Jones, M. Bobko, 2002, Bioorganic & medicinal chemistry letters.

The position of the dinitrophenyl group in im-dinitrophenylhistidine derivatives.

J. Jones, J. R. Bell, 1974, Journal of the Chemical Society. Perkin transactions 1.

A list of amino-acid derivatives which are useful in peptide synthesis.

J. Jones, G. A. Fletcher, 2009, International journal of peptide and protein research.

Sequential polypeptides. Part X. The synthesis of some sequential polypeptide collagen models with functional side-chains.

J. Jones, J. R. Bell, T. Webb, 2009, International journal of peptide and protein research.

A supplementary list of amino-acid derivatives which are useful in peptide synthesis.

J. Jones, G. A. Fletcher, 2009, International journal of peptide and protein research.

Sequential Polypeptide Synthesi

J. Jones, H. Goren, 1974 .

Sequential polypeptides. Part IX. The synthesis of two sequential polypeptide elastin models.

J. Jones, R. Boohan, J. R. Bell, 2009, International journal of peptide and protein research.

The mass spectra of amino-acid and peptide derivatives. II. Phthaloylamino-acids.

R. Aplin, J. Jones, 1968, Journal of The Chemical Society-perkin Transactions 1.

The mass spectra of amino‐acid and peptide derivatives—III:. A comparison of the utility of various N‐protecting groups

I. Eland, R. Aplin, J. Jones, 1969 .

6-Substituted 5-chloro-1,3-dihydro-2H-imidazo(4,5-b)pyrazin-2-ones with hypotensive activity.

J. Jones, E. Cragoe, W. J. Holtz, 1973, Journal of medicinal chemistry.

Homo-oligohistidines. I: Synthesis, characterisation and preferred solid state conformations of a series of N(α)-t-butoxycarbonyl, N(π)-benzyloxymethyl-homo-oligo-L-histidine methyl esters, from the dipeptide to the heptapeptide

C. Toniolo, G. Bonora, J. Jones, 2009 .

Hono-oligohistidines. II: Preferred conformations in solution of a series of N(α-t-butoxycarbonyl, N(π)-benzyloxyméthyl-homo-oligo-L-histidine méthyl esters, from the dipeptide to the heptapeptide

C. Toniolo, G. Bonora, J. Jones, 2009 .

Metal complexes of amino acids and peptides

J. Jones, K. Nolan, R. Hay, 2002 .

Mechanism of racemisation of histidine derivatives in peptide synthesis.

M. Witty, J. Jones, W. Ramage, 2009, International journal of peptide and protein research.

The Regiospecific Alkylation of Histidine Side Chains

P. B. Wyatt, J. Jones, D. Rathbone, 1988 .

The antigenicity of sequential polypeptides. I. The synthesis of some sequential collagen models.

J. Jones, R. Fairweather, 1973, Immunology.

Sequential polypeptides. Part IV. The synthesis of poly-(L-alanyl-giycyi-L-proline) and its stereoisomers

J. Jones, R. Fairweather, 1972 .

Amino-acids and peptides. XXIV. The use of esters of 1-hydroxypiperidine and of other NN-dialkylhydroxylamines in peptide synthesis and as selective acylating agents.

J. Jones, T. Johnson, G. T. Young, 1965, Journal of the Chemical Society. Perkin transactions 1.

Pyrazine diuretics. II. N-amidino-3-amino-5-substituted 6-halopyrazinecarboxamides.

J. Jones, E. Cragoe, O. W. Woltersdorf, 1967, Journal of medicinal chemistry.

Pyrazine diuretics. V. N-Amidino-3-aminopyrazinecarboxamidines and analogous 2,4-diaminopteridines.

J. Jones, E. Cragoe, 1968, Journal of medicinal chemistry.

Pyrazine diuretics. 8. N-Amidino-3-aminopyrazinecarboxamide 4-oxides.

J. Jones, E. Cragoe, 1970, Journal of medicinal chemistry.

Pyrazine diuretics. VI. (Pyrazinecarboxamido)guanidines.

K. Shepard, J. Jones, E. Cragoe, 1969, Journal of medicinal chemistry.

Pyrazine diuretics. VII. N-amidino-3-substituted pyrazinecarboxamides.

J. Jones, E. Cragoe, W. J. Holtz, 1969, Journal of medicinal chemistry.

Pyrazine diuretics. IV. N-amidino-3-amino-6-substituted pyrazinecarboxamides.

J. Jones, E. Cragoe, J. Bicking, 1967, Journal of medicinal chemistry.

Selectivity of (+)-4-propyl-9-hydroxynaphthoxazine [(+)-PHNO] for dopamine receptors in vitro and in vivo.

V. J. Lotti, D. Taylor, M. Williams, 1985, The Journal of pharmacology and experimental therapeutics.

Pharmacologic profile of a novel potent direct-acting dopamine agonist, (+)-4-propyl-9-hydroxynaphthoxazine [(+)-PHNO].

M. Williams, J. Jones, G. Yarbrough, 1984, The Journal of pharmacology and experimental therapeutics.

A synthetic polypeptide related to elastin and its interaction with calcium ions.

J. Jones, R. Boohan, J. R. Bell, 2009, International journal of peptide and protein research.

Synthesis of 4-substituted 2H-naphth[1,2-b]-1,4-oxazines, a new class of dopamine agonists.

G. F. Lundell, P. Anderson, J. Hirshfield, 1984, Journal of medicinal chemistry.

Sequential polypeptides. VI. The synthesis of some sequential polypeptide collagen models containing proline analogues.

J. Jones, R. Fairweather, 1972, Journal of the Chemical Society. Perkin transactions 1.

Synthesis of the sultam analog of 11-deoxy PGE2.

J. Jones, E. Cragoe, J. Bicking, 1979, Prostaglandins.

Synthesis of (7R)-7H-indolo[3,4-gh][1,4]benzoxazines, a new class of D-heteroergolines with dopamine agonist activity.

G. F. Lundell, P. Anderson, J. Hirshfield, 1983, Journal of medicinal chemistry.

The mass spectra of amino-acids and peptides: benzyl migration in benzyloxycarbonyl derivatives

R. Aplin, J. Jones, B. Liberek, 1966 .

Integration of optimized substituent patterns to produce highly potent 4-aryl-pyridine glucagon receptor antagonists.

J. Livingston, J. Jones, Roger A. Smith, 2002, Bioorganic & medicinal chemistry letters.

11,12-secoprostaglandins. 4. 7-(N-alkylmethanesulfonamido) heptanoic acids.

J. Jones, E. Cragoe, W. J. Holtz, 1977, Journal of medicinal chemistry.

Rational Design and Optimization of a Novel Class of Macrocyclic ASK1 Inhibitors.

I. Enyedy, J. Jones, Joshua L. Johnson, 2019, Journal of medicinal chemistry.

Inhibition of postsynaptic dopamine-sensitive adenylate cyclase in carp retina by the putative dopamine autoreceptor agonist, 3-PPP.

M. Williams, J. Jones, K. Watling, 1982, European Journal of Pharmacology.

Syntheses of thyroliberin analogues in which the C-terminal amide and the τ-position of the histidine side-chain are bridged. Regiospecific τ-im-alkylation and 2-hydroxyphenyl ester cyclopeptide synthesis exemplified

P. B. Wyatt, J. Jones, 1990 .